Association of somatic mutations and histologic subtype/grade on prognosis and PD-L1 expression in mesothelioma von Zhu, Allen, Husain, Aliya N., Hermina, Andrew, Mitchell, Owen, Mueller, Jeffrey S., Drazer, Michael William, Kindler, Hedy L., Kwon, Jung Woo

Volltext

A phase I study of MEK inhibitor selumetinib in combination with azacitidine in patients with higher-risk chronic myeloid neoplasia von Roloff, Gregory, Patel, Anand Ashwin, Pettit, Kristen M, Thirman, Michael J., Larson, Richard A., Nawas, Mariam, Kosuri, Satyajit, Drazer, Michael William, Fulton, Noreen, Weiner, Howard, Stock, Wendy, Liu, Hongtao, Odenike, Olatoyosi

Volltext

National prostate cancer screening rates following the 2012 United States Preventive Services Task Force recommendation discouraging prostate-specific antigen (PSA)-based screening von Drazer, Michael William, Huo, Dezheng, Eggener, Scott E.

Volltext

Therapy-Related Myeloid Neoplasms in 109 Patients Following Radiation Monotherapy von Patel, Anand Ashwin, Rojek, Alexandra E, Drazer, Michael William, Weiner, Howard, Godley, Lucy Ann, Le Beau, Michelle M., Larson, Richard A.

Volltext

National trends in prostate cancer screening among older American men with limited 9‐year life expectancies: Evidence of an increased need for shared decision making von Drazer, Michael W., Prasad, Sandip M., Huo, Dezheng, Schonberg, Mara A., Dale, William, Szmulewitz, Russell Z., Eggener, Scott E.

Volltext

PSA screening rates in older men in the United States based on nine-year estimated remaining life expectancy von Drazer, Michael, Prasad, Sandip M., Huo, Dezheng, Schonberg, Mara A, Szmulewitz, Russell Zelig, Dale, William, Eggener, Scott E.

Volltext